Adverse Effects of Osteocytic Constitutive Activation of ß-Catenin on Bone Strength and Bone Growth

Journal of Bone and Mineral Research

Volumn 30, Issue 7, 2015, Pages 1184-1194

  Chen, Sixu ^a,b   Feng, Jianquan ^c   Bao, Quanwei ^a   Li, Ang ^a   Zhang, Bo ^a   Shen, Yue ^a   Zhao, Yufeng ^a   Guo, Qingshan ^a   Jing, Junjun ^c   Lin, Shuxian ^c   Zong, Zhaowen ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b The 118th PLA Hospital   (China)

^c BAYLOR COLLEGE OF DENTISTRY   (United States)

Author keywords

BONE REMODELING; GENETIC ANIMAL MODELS; MATRIX MINERALIZATION; OSTEOCYTES; CATENIN

Indexed keywords

BETA CATENIN; BIOLOGICAL MARKER; DENTIN MATRIX PROTEIN 1; PHOSPHATE; CRE RECOMBINASE; DMP1 PROTEIN, MOUSE; INTEGRASE; SCLEROPROTEIN;

ADVERSE OUTCOME; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BONE GROWTH; BONE MINERALIZATION; BONE REMODELING; BONE STRENGTH; ENZYME ACTIVATION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCYTE; PHOSPHATE BLOOD LEVEL; SHORT STATURE; TRABECULAR BONE; TRANSGENIC MOUSE; WNT SIGNALING PATHWAY; ANIMAL; BIOMECHANICS; BONE; BONE DEVELOPMENT; METABOLISM; PHYSIOLOGY;

ANIMALS; BETA CATENIN; BIOMECHANICAL PHENOMENA; BONE AND BONES; BONE DEVELOPMENT; CALCIFICATION, PHYSIOLOGIC; EXTRACELLULAR MATRIX PROTEINS; INTEGRASES; MICE, TRANSGENIC; OSTEOCYTES;

EID: 84931828687     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2453     Document Type: Article

References (36)

1. Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, et al., LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell. 2001; Nov 16 107 (4): 513-23.
2. Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, et al., A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet. 2002; Jan 70 (1): 11-9.
3. Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, et al., High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med. 2002; May 16 346 (20): 1513-21.
4. Chen J, Long F,. Beta-catenin promotes bone formation and suppresses bone resorption in postnatal growing mice. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research. 2013; May 28 (5): 1160-9.
5. Holmen SL, Zylstra CR, Mukherjee A, Sigler RE, Faugere MC, Bouxsein ML, et al., Essential role of beta-catenin in postnatal bone acquisition. The Journal of biological chemistry. 2005; Jun 3 280 (22): 21162-8.
6. Wan Y, Lu C, Cao J, Zhou R, Yao Y, et al., Osteoblastic Wnts differentially regulate bone remodeling and the maintenance of bone marrow mesenchymal stem cells. Yu J 2013; Jul 55 (1): 258-67.
7. Glass DA II, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, et al., Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Developmental cell. 2005 May; 8 (5): 751-64.
8. Cawthorn WP, Bree AJ, Yao Y, Du B, Hemati N, Martinez-Santibanez G, et al., Wnt6, Wnt10a and Wnt10b inhibit adipogenesis and stimulate osteoblastogenesis through a beta-catenin-dependent mechanism. Bone. 2012; Feb 50 (2): 477-89.
9. McClung MR, Grauer A, Boonen S, Bolognese MA, Brown JP, Diez-Perez A, et al., Romosozumab in postmenopausal women with low bone mineral density. The New England journal of medicine. 2014; Jan 30 370 (5): 412-20.
10. Jia M, Chen S, Zhang B, Liang H, Feng J, Zong Z,. Effects of constitutive beta-catenin activation on vertebral bone growth and remodeling at different postnatal stages in mice. PloS one. 2013; 8 (9): e74093.
11. Rossini M, Gatti D, Adami S,. Involvement of WNT/beta-catenin signaling in the treatment of osteoporosis. Calcified tissue international. 2013; Aug 93 (2): 121-32.
12. Minear S, Leucht P, Miller S, Helms JA,. RBMP represses Wnt signaling and influences skeletal progenitor cell fate specification during bone repair. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research. 2010; Jun 25 (6): 1196-207.
13. Kansara M, Tsang M, Kodjabachian L, Sims NA, Trivett MK, Ehrich M, et al., Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice. The Journal of clinical investigation. 2009; Apr 119 (4): 837-51.
14. Kode A, Manavalan JS, Mosialou I, Bhagat G, Rathinam CV, Luo N, et al., Leukaemogenesis induced by an activating beta-catenin mutation in osteoblasts. Nature. 2014; Feb 13 506 (7487): 240-4.
15. Javaheri B, Stern AR, Lara N, Dallas M, Zhao H, Liu Y, et al., Deletion of a Single beta-Catenin Allele in Osteocytes Abolishes the Bone Anabolic Response to Loading. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research. 2014; Mar 29 (3): 705-15.
16. Rochefort GY, Pallu S, Benhamou CL,. Osteocyte: the unrecognized side of bone tissue. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2010 Sep; 21 (9): 1457-69.
17. Feng JQ, Clinkenbeard EL, Yuan B, White KE, Drezner MK,. Osteocyte regulation of phosphate homeostasis and bone mineralization underlies the pathophysiology of the heritable disorders of rickets and osteomalacia. Bone. 2013; Jun 54 (2): 213-21.
18. Burgers TA, Williams BO,. Regulation of Wnt/beta-catenin signaling within and from osteocytes. Bone. 2013; Jun 54 (2): 244-9.
19. Case N, Rubin J,. Beta-catenin-a supporting role in the skeleton. Journal of cellular biochemistry. 2010; Jun 1 110 (3): 545-53.
20. Kramer I, Halleux C, Keller H, Pegurri M, Gooi JH, Weber PB, et al., Osteocyte Wnt/beta-catenin signaling is required for normal bone homeostasis. Molecular and cellular biology. 2010; Jun 30 (12): 3071-85.
21. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R,. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research. 2010; Jul 25 (7): 1468-86.
22. Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, et al., Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research. 2013; 28 (1): 2-17.
23. Bakker AD, Klein-Nulend J,. Osteoblast isolation from murine calvaria and long bones. Methods in molecular biology. 2012; 816: 19-29.
24. Stern AR, Stern MM, Van Dyke ME, Jahn K, Prideaux M, Bonewald LF,. Isolation and culture of primary osteocytes from the long bones of skeletally mature and aged mice. BioTechniques. 2012; Jun 52 (6): 361-73.
25. Orimo H,. The mechanism of mineralization and the role of alkaline phosphatase in health and disease. Journal of Nippon Medical School = Nippon Ika Daigaku zasshi. 2010; Feb 77 (1): 4-12.
26. Martin A, Quarles LD,. Evidence for FGF23 involvement in a bone-kidney axis regulating bone mineralization and systemic phosphate and vitamin D homeostasis. Advances in experimental medicine and biology. 2012; 728: 65-83.
27. Li X, Liu P, Liu W, Maye P, Zhang J, Zhang Y, et al., Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation. Nature genetics. 2005; Sep 37 (9): 945-52.
28. van der Horst G, van der Werf SM, Farih-Sips H, van Bezooijen RL, Lowik CW, Karperien M,. Downregulation of Wnt signaling by increased expression of Dickkopf-1 and -2 is a prerequisite for late-stage osteoblast differentiation of KS483 cells. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research. 2005; Oct 20 (10): 1867-77.
29. Day TF, Guo X, Garrett-Beal L, Yang Y,. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Developmental cell. 2005; May 8 (5): 739-50.
30. Hill TP, Spater D, Taketo MM, Birchmeier W, Hartmann C,. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Developmental cell. 2005; May 8 (5): 727-38.
31. Li X, Ominsky MS, Niu QT, Sun N, Daugherty B, D'Agostin D, et al., Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research. 2008; Jun 23 (6): 860-9.
32. Ke HZ, Richards WG, Li X, Ominsky MS,. Sclerostin and dickkopf-1 as therapeutic targets in bone diseases. Endocrine Review. 2012; Oxt 33 (5): 747-83.
33. Romero G, Sneddon WB, Yang Y, Wheeler D, Blair HC, Friedman PA,. Parathyroid hormone receptor directly interacts with dishevelled to regulate beta-Catenin signaling and osteoclastogenesis. J Biol Chem. 2010; May 7 285 (19): 14756-63.
34. Davison KS, Siminoski K, Adachi JD, Hanley DA, Goltzman D, Hodsman AB, et al., Bone strength: the whole is greater than the sum of its parts. Seminars in arthritis and rheumatism. 2006; Aug 36 (1): 22-31.
35. Miclea RL, Karperien M, Bosch CA, van der Horst G, van der Valk MA, Kobayashi T, et al., Adenomatous polyposis coli-mediated control of beta-catenin is essential for both chondrogenic and osteogenic differentiation of skeletal precursors. BMC developmental biology. 2009; Apr 9: 26.
36. Wang B, Jin H, Zhu M, Li J, Zhao L, Zhang Y, et al., Chondrocyte β-catenin signaling regulates postnatal bone remodeling through modulation of osteoclast formation in a murine model. Arthritis Rheumatol. 2014; Jan 66 (1): 107-20.